124 related articles for article (PubMed ID: 35718445)
1. Significance of interstitial fibrosis and p16 in papillary thyroid carcinoma.
Wang HQ; Li Y; Song X; Ma YQ; Li JL; Li YX; Wang GF; Liu P; Liu PL; Cao S; Shi HY
Endocr J; 2022 Oct; 69(10):1253-1259. PubMed ID: 35718445
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of patient age in papillary thyroid carcinoma with no high-risk features.
Ito Y; Miyauchi A; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A
Endocr J; 2022 Sep; 69(9):1131-1136. PubMed ID: 35431281
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
5. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
6. Implications of Extrathyroidal Extension Invading Only the Strap Muscles in Papillary Thyroid Carcinomas.
Li G; Li R; Song L; Chen W; Jiang K; Tang H; Wei T; Li Z; Gong R; Lei J; Zhu J
Thyroid; 2020 Jan; 30(1):57-64. PubMed ID: 31830859
[No Abstract] [Full Text] [Related]
7. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
[TBL] [Abstract][Full Text] [Related]
8. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
9. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
10. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
11. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
12. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
13. Methylation of p16 CpG islands correlated with metastasis and aggressiveness in papillary thyroid carcinoma.
Wang P; Pei R; Lu Z; Rao X; Liu B
J Chin Med Assoc; 2013 Mar; 76(3):135-9. PubMed ID: 23497965
[TBL] [Abstract][Full Text] [Related]
14. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
15. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.
Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S
Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Forkhead box Q1 correlates with poor prognosis in papillary thyroid carcinoma.
Li Y; Wang HQ; Wang AC; Li YX; Ding SS; An XJ; Shi HY
Clin Endocrinol (Oxf); 2019 Feb; 90(2):334-342. PubMed ID: 30378716
[TBL] [Abstract][Full Text] [Related]
18. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
Chen X; Jin J; Zheng L; Sheng Y; Sun J
J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
[TBL] [Abstract][Full Text] [Related]
19. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
20. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
Lee YA; Jung HW; Kim HY; Choi H; Kim HY; Hah JH; Park DJ; Chung JK; Yang SW; Shin CH; Park YJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1619-29. PubMed ID: 25632969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]